Skye formulation accepted for GSK drug
UK firm SkyePharma last week announced that the US Food and Drug Administration (FDA) has accepted a filing for the extended release formulation of partner GlaxoSmithKline's (GSK) drug Requip (ropinirole).
Archives for April 15, 2007
IMA buys out rival
The IMA Group announced late last week that it has successfully bought one of its leading competitors in a deal worth €1.4m.
Jurassic Spark - Dino movie inspires stem cell fertility treatment
A new study has shown that certain human bone marrow stem cells can differentiate into sperm stem cells - potentially leading to a revolution in fertility therapy.
Exubera has opened door for pulmonary delivery growth
While the market performance of Exubera may have fallen short of expectations, Pfizer's inhaled insulin has opened the door for a wider variety of macromolecules to take the pulmonary delivery route.
Polymeric pain relief product to hit the shelves
US firm Skinvisible last week announced that its polymer-based delivery system has been licensed to pain relief company DRJ for use in a new topical analgesic product.
Galapagos inks two 'major' contracts
Galapagos' recent acquisitions seem to be paying off as the Belgian biotech firm has announced its contract services unit BioFocus DPI has inked two new deals with Japan-based Ono Pharmaceutical.
Contract manufacturing news in brief
Hyaluron, MultiCell Technologies and Affitech have all announced new contract manufacturing deals this week.
GSK meet no resistance for new antibacterial
The approval of GlaxoSmithKline's (GSK) Altabax gives clinicians the first new class of topical antibacterial treatments in nearly 20 years - adding more firepower to the fight against bacterial resistance.